inan Trio Pharmatech Co., Ltd. locates at China Jinan Overseas Scholar Pioneer Park and Jinan High-Tech Development Zone, and benefits from the preferential policies and supports provided by Qilu SAR personnel and State new drug innovation platform (Shandong).
The Company was founded by a core group of top overseas pharmaceutical chemists, medical scientists and business management experts, and was identified as a service outsourcing enterprise by the Ministry of Commerce in 2011.
The Company integrates R&D, manufacture, sales and technical training, and focuses on developing novel anticancer drugs. We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway inhibitors, pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom synthesis, transfer of new drug patent and technology, technical cooperation, and process optimization.
Our company advocates “People First and Technology First”. We try our best to forge a high level, high performance and high technology venture team. The Company was awarded as “High-Level Personnel Entrepreneurial Advanced Unit” by Jinan High-Tech Development Zone in 2011. The founders were awarded “Spring City Specially Invited Expert” by Jinan Municipal Government, and “Taishan Scholar Oversea Distinguished Entrepreneurial Expert” and “Entrepreneurship Award for Returning Oversea Scholar” by Shandong Provincial government.
We are highly praised by our clients and partners for our best service and quality. We have built up solid cooperation with ov
何银杰 出资金额：30万元 高砚芳 出资金额：1万元 孙学英 出资金额：70万元
孙学英 职位：执行董事 高砚芳 职位：监事 何银杰 职位：经理
变更项目：换照 更新后 2014-08-05 换发新证 更新前